[ad_1]
Daniela Molena, MD, director of the Memorial Sloan Kettering Cancer Center's Esophageal Surgery Program, explains what she believes to be the Achilles' heel of endoscopic resection in patients with severe pain. a cancer of the esophagus.
According to Molena, the current challenge is the inability to predict nodal disease. It is not known if a patient has it or not, but the characteristics of the tumor can be used to estimate the risk of ganglionic disease.
If a patient is at high risk, endoscopic resection is not a good option. instead, they should have a more aggressive approach. For people at low risk, endoscopic resection is a safe option. Molena says that it is necessary to find ways to identify ganglionic disease in patients without having to predict the risk.
Learn more about the 2019 Symposium on Gastrointestinal Cancer
Source link
